Benaroya Research Institute Welcomes Three New Board Members

Seattle, WA

Benaroya Research Institute at Virginia Mason (BRI) announced three new members to its Board of Directors:  Nabil Istafanous, Ben Reiber and Catherine Zimmerman.

Nabil Istafanous, JD, is Principal, Corporate Counsel Solutions PLLC and an experienced governance, compliance and ethics consultant and healthcare attorney. Previously he has served as the Chief Compliance and Ethics officer for Group Health and Premera Blue Cross.

Ben Reiber, MBA, CFA, is Vice President, Investment Management Division, Goldman, Sachs & Co. where he is focused on investment management, strategic and tactical asset allocation and financial risk management for individuals, foundations and companies.

Catherine Zimmerman is a human resources professional, previously employed by Merck & Co.,  currently serving as a mediator and conflict resolution coach.  She has served on the AJC Seattle Regional Board and received a Bronze Presidential Volunteer Service Award for mediation from the City of Bellevue.

“We’re grateful to these individuals for volunteering their valuable time and support,” said Gerald Nepom, MD, PhD, director of BRI, “I’m certain that along with our other distinguished board members, their guidance will continue to ensure BRI’s leadership in scientific innovation and medical advancements.” 

Benaroya Research Institute at Virginia Mason (BRI) is committed to finding causes and cures for autoimmune diseases such as type 1 diabetes, rheumatoid arthritis, inflammatory bowel disease and multiple sclerosis, and immune system diseases such as allergies and asthma.  An internationally-recognized medical research institute, BRI accelerates discovery through laboratory breakthroughs in immunology that are then translated to clinical therapies.  BRI is a leader of collaborative initiatives through the Immune Tolerance Network and other major cooperative research programs.  Visit or follow Benaroya Research Institute on Facebook to learn more.

Media Contact:

Kay Branz
Director, Marketing Communications & External Relations / 206-342-6903

Learn the Latest

A sample printed newsletterSign up for our news & updates and learn the latest in the fight against autoimmune diseases.

Sign up today